Carrie Claycomb
Physician Assistant · Orbisonia, PANPI 1386125177
Payments from drug & device makers
Across 284 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$999
- Boehringer Ingelheim$652
- Lilly USA, LLC$609
- GSK$452
- AstraZeneca$413
- AbbVie$320
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,43399%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 62 | $999 |
| Boehringer Ingelheim | 50 | $652 |
| Lilly USA, LLC | 48 | $609 |
| GSK | 35 | $452 |
| AstraZeneca | 23 | $413 |
| AbbVie | 14 | $320 |
| Daiichi Sankyo Inc. | 9 | $203 |
| Exact Sciences | 5 | $118 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $116 |
| Sumitomo Pharma America, Inc. | 5 | $109 |
| Astellas Pharma US Inc | 5 | $93 |
| Sanofi-aventis U.S. LLC | 4 | $64 |
| Myriad Women's Health, Inc. | 1 | $49 |
| Nevro Corp. | 1 | $46 |
| Johnson & Johnson | 2 | $35 |
| Novartis | 2 | $30 |
| Bayer | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Pfizer | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$4,458 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 267 | $233,106 |
| OzempicSemaglutide | 187 | $227,959 |
| EliquisApixaban | 194 | $125,017 |
| MounjaroTirzepatide | 55 | $77,603 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 78 | $60,109 |
| MyrbetriqMirabegron | 71 | $36,327 |
| EntrestoSacubitril/Valsartan | 42 | $33,931 |
| TrulicityDulaglutide | 21 | $32,486 |
| FarxigaDapagliflozin Propanediol | 40 | $26,186 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $25,778 |
| XareltoRivaroxaban | 42 | $25,550 |
| LinzessLinaclotide | 32 | $24,919 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $24,725 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 26 | $23,995 |
| Nurtec OdtRimegepant Sulfate | 12 | $23,589 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Wegovy | $999 | $265,166213 claims |
| Boehringer IngelheimJardiance | $652 | $233,106267 claims |
| PfizerEliquis, Nurtec Odt | $14 | $148,606206 claims |
| Lilly USA, LLCMounjaro, Trulicity | $609 | $110,08976 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $452 | $79,460109 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $413 | $50,91170 claims |
| Astellas Pharma US IncMyrbetriq | $93 | $36,32771 claims |
| NovartisEntresto | $30 | $33,93142 claims |
| Johnson & JohnsonXarelto | $35 | $25,55042 claims |
| AbbVieLinzess | $320 | $24,91932 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $64 | $23,99526 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $116 | $8,75611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Orbisonia
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.